Beacon Trust’s Novartis NVS Stock Holding History

Beacon Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$392K	Hold	5,588	–	–	0.06%	139
2016 Q4	$364K	Buy	5,588 +64	+1%	+$4.15K	0.06%	141
2016 Q3	$391K	Sell	5,524 -502	-8%	-$36.6K	0.07%	135
2016 Q2	$446K	Hold	6,026	–	–	0.08%	135
2016 Q1	$391K	Hold	6,026	–	–	0.07%	132
2015 Q4	$464K	Hold	6,026	–	–	0.08%	127
2015 Q3	$496K	Hold	6,026	–	–	0.09%	126
2015 Q2	$531K	Sell	6,026 -84	-1%	-$7.71K	0.09%	124
2015 Q1	$540K	Sell	6,110 -168	-3%	-$14.9K	0.08%	134
2014 Q4	$521K	Sell	6,278 -161	-3%	-$13.3K	0.08%	138
2014 Q3	$543K	Hold	6,439	–	–	0.09%	130
2014 Q2	$523K	Sell	6,439 -123	-2%	-$9.68K	0.09%	128
2014 Q1	$500K	Sell	6,562 -10,062	-61%	-$733K	0.09%	128
2013 Q4	$1.2M	Sell	16,624 -1,960	-11%	-$136K	0.21%	97
2013 Q3	$1.28M	Sell	18,584 -34	-0.2%	-$2.25K	0.24%	95
2013 Q2	$1.18M	Buy	+18,618	New	+$1.21M	0.22%	95

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Beacon Trust's NVS Position: Q1 2017 in Review

Beacon Trust held its Novartis (NVS) position steady in Q1 2017 at 5,588 shares worth $392K. The position accounts for 0.06% of the portfolio, ranked #139.

Beacon Trust first reported a position in NVS in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.28M in Q3 2013. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Beacon Trust held 5,588 shares of Novartis worth $392K as of Q1 2017.
Beacon Trust left its Novartis share count unchanged in Q1 2017.
Novartis made up 0.06% of Beacon Trust's portfolio in Q1 2017, its #139 holding.
Beacon Trust first reported a position in Novartis in Q2 2013 and has held it in 16 quarters since.
Beacon Trust's Novartis position peaked at $1.28M in Q3 2013.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.